Brandywine Managers, LLC Bluebird Bio, Inc. Transaction History

Brandywine Managers, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$26.16 - $63.5 $73,248 - $177,800	-2,800 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$46.96 - $61.67 $14,088 - $18,501	300 Added 12.0%	2,800 $246,000
Q3 2019 Nov 13, 2019	BUY	$59.47 - $93.1 $29,735 - $46,550	500 Added 25.0%	2,500 $230,000
Q1 2019 May 14, 2019	BUY	$64.44 - $104.11 $128,880 - $208,220	2,000 New	2,000 $315,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Brandywine Managers, LLC, based on Form 13F filings with the SEC.

Stay updated on Brandywine Managers, LLC with notifications on news.